Table of Contents
ISRN Spectroscopy
Volume 2012 (2012), Article ID 648510, 10 pages
http://dx.doi.org/10.5402/2012/648510
Research Article

Use of Alizarin Red S as an Ion-Pair Reagent for the Spectrophotometric Assay of Fexofenadine in Pharmaceuticals and in Spiked Human Urine

Department of Chemistry, University of Mysore, Manasagangotri Campus, Mysore, Karnataka 570006, India

Received 19 October 2012; Accepted 19 November 2012

Academic Editors: C. Liang and I. Milošev

Copyright © 2012 Madihalli S. Raghu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. The Merck, The Merck Index, An Encyclopedia of Chemicals, Drugs, And Biologicals, Merck & Company, Whitehouse Station, NJ, USA, 2001.
  2. C. Dollery, Therapeutic Drugs, Churchill Livingstone, London, UK, 2nd edition, 1999.
  3. “The United States Pharmacopoeia,” 24th Revision, the 19th National Formulary, USP Convention, Rockville, Md, USA, 2000.
  4. A. R. Breier, C. S. Paim, M. Steppe, and E. E. S. Schapoval, “Development and validation of dissolution tests of fexofenadine hydrochloride capsules and coated tablets,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 8, no. 2, pp. 289–298, 2005. View at Google Scholar · View at Scopus
  5. H. M. Maher, M. A. Sultan, and I. V. Olah, “Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets,” Chemistry Central Journal, vol. 5, no. 1, article 76, 2011. View at Publisher · View at Google Scholar
  6. T. Radhakrishna and G. Om Reddy, “Simultaneous determination of fexofenadine and its related compounds by HPLC,” Journal of Pharmaceutical and Biomedical Analysis, vol. 29, no. 4, pp. 681–690, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. F. Zafar, M. H. Shoaib, and R. I. Yousuf, “Development of Rp-HPLC method for fexofenadine determination in tablet formulations and development of dissolution method,” Pakistan Journal of Pharmacology, vol. 28, pp. 43–49, 2011. View at Google Scholar
  8. B. R. Vaghela, A. M. Reddy, P. Venkatesh, and N. Kumar, “Identification and characterization of an oxidative degradation product of fexofenadine, development and validation of a stability-indicating RP-UPLC method for the estimation of process related impurities and degradation products of fexofenadine in pharmaceutical formulations,” Scientia Pharmaceutica, vol. 80, no. 2, pp. 295–309, 2012. View at Publisher · View at Google Scholar
  9. S. Karakus, I. Küçükgüzel, and S. G. Küçükgüzel, “Development and validation of a rapid RP-HPLC method for the determination of cetirizine or fexofenadine with pseudoephedrine in binary pharmaceutical dosage forms,” Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 2, pp. 295–302, 2008. View at Publisher · View at Google Scholar
  10. M. K. Sharaf El- Din, F. Irahim, M. I. Eid, and M. E. K. Wahb, “Validated stability indicating liquid chromatographic method for the determination of fexofenadine hydrochloride in presence of its degradation products application to tablets and content uniformity testing,” Journal of Pharmacy Research, vol. 4, no. 7, pp. 2377–2380, 2011. View at Google Scholar
  11. D. C. Oliveira, A. Weich, and C. M. B. Rolim, “Simple and reliable HPLC analysis of fexofenadine hydrochloride in tablets and its application to dissolution studies,” Pharmazie, vol. 62, no. 2, pp. 96–100, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Cui, L. Qian, S. Hong-Wei, Y. Lun, S. Zhen-Peng, and L. Hong, “Determination of fexofenadine hydrochloride and its related substances by HPLC,” Chinese Journal of New Drugs, no. 18, pp. 1511–1513, 2007. View at Google Scholar
  13. M. S. Arayne, N. Sultana, H. Shehnaz, and A. Haider, “RP-HPLC method for the quantitative determination of fexofenadine hydrochloride in coated tablets and human serum,” Medicinal Chemistry Research, vol. 20, no. 1, pp. 55–61, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. A. Alothman, N. Bukhari, S. Haider, S. M. Wabaidur, and A. A. Alwarthan, “Spectrofluorimetric determination of fexofenadine hydrochloride in pharmaceutical preparation using silver nanoparticles,” Arabian Journal of Chemistry, vol. 3, no. 4, pp. 251–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. P. Mikuš, I. Valášková, and E. Havránek, “Determination of fexofenadine in tablets by capillary electrophoresis in free solution and in solution with cyclodextrins as analyte carriers,” Drug Development and Industrial Pharmaceuticals, vol. 31, no. 8, pp. 795–801, 2005. View at Publisher · View at Google Scholar
  16. A. Golcu, B. Dogan, and S. A. Ozkan, “Anodic voltammetric behavior and determination of antihistaminic agent: fexofenadine HCl,” Analytical Letters, vol. 38, no. 12, pp. 1913–1931, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. İ. Kozan, I. M. Palabiyik, E. Karacan, and F. Onur, “Spectrophotometric and high performance liquid chromatographic determination of fexofenadine hydrochloride in pharmaceutical formulations,” Turkish Journal of Pharmaceutical Sciences, vol. 5, no. 3, pp. 175–189, 2008. View at Google Scholar · View at Scopus
  18. H. J. Vekaria, K. S. Muralikrishna, and G. F. Patel, “Development and validation of spectrophotometric method for estimation of fexofenadine hydrochloride and montelukast sodium in combined dosage form,” Inventi Impact: Pharm Analysis & Quality Assurance, vol. 2011, Article ID Inventi:ppaqa/240/11, 2011. View at Google Scholar
  19. A. R. Breier, M. Steppe, and E. E. S. Schapoval, “Validation of UV spectrophotometric method for fexofenadine hydrochloride in pharmaceutical formulations and comparison with HPLC,” Analytical Letters, vol. 40, no. 12, pp. 2329–2337, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. N. Abbas, A. A. A. Fattah, and E. Zahran, “A novel membrane sensor for histamine H1-receptor antagonist ‘fexofenadine’,” Analytical Sciences, vol. 20, no. 8, pp. 1137–1142, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Narayana and K. Veena, “A new method for the spectrophotometric determination of fexofenadine hydrochloride,” Indian Journal of Chemical Technology, vol. 17, no. 5, pp. 386–390, 2010. View at Google Scholar · View at Scopus
  22. K. S. Kumar, V. Ravichandran, M. K. Mohan Maruga Raja, R. Thyagu, and A. Dharamsi, “Spectrophotometric determination of Fexofenadine hydrochloride,” Indian Journal of Pharmaceutical Sciences, vol. 68, no. 6, pp. 841–842, 2006. View at Google Scholar · View at Scopus
  23. S. S. Abd El-Hay, M. Y. El-Mammli, and A. A. Shalaby, “Spectrophotometric determination of clemastine hydrogen fumarate, fexofenadine HCl and moxepril HCl through ion-pair formation with chromatrope 2 R,” Research Journal of Pharmaceutical, Biological and Chemical Sciences, vol. 2, no. 1, pp. 497–509, 2011. View at Google Scholar · View at Scopus
  24. S. A. Alaa, S. A. Ibrahim, and A. M. Hassan, “Utility of extracted colored ion—associate complexes formation reaction for the determination of fexofenadine hydrochloride in pure forms and in dosage forms,” Journal of Chemical Engineering & Process Technology, vol. 1, article 101, 2010. View at Publisher · View at Google Scholar
  25. L. D. Srinivas, P. Ravi kumar, and B. S. Sastry, “Ion association methods for the determination of fexofenadine in pharmaceutical preparations,” E-Journal of Chemistry, vol. 2, no. 3, pp. 199–202, 2005. View at Publisher · View at Google Scholar
  26. S. Ashour, M. F. Chehna, and R. Bayram, “Spectrophotometric determination of alfuzosin HCl in pharmaceutical formulations with some sulphonephthalein dyes,” International Journal of Biomedical Science, vol. 2, no. 3, pp. 273–278, 2006. View at Google Scholar
  27. K. Harikrishna, B. S. Nagaralli, and J. Seetharamappa, “Extractive spectrophotometric determination of sildenafil citrate (viagra) in pure and pharmaceutical formulations,” Journal of Food and Drug Analysis, vol. 16, no. 1, pp. 11–17, 2008. View at Google Scholar · View at Scopus
  28. N. Rajendraprasad, K. Basavaiah, K. B. Vinay, and H. D. Revanasiddappa, “Sensitive and selective extractive spectrophotometric method for the determination of hydroxyzine dihydrochloride in pharmaceuticals,” Journal of the Mexican Chemical Society, vol. 54, no. 4, pp. 233–239, 2010. View at Google Scholar · View at Scopus
  29. N. Rajendraprasad, K. Basavaiah, and K. B. Vinay, “Extrtactive spectrophotometric determination of quetiapine fumarate in pharmaceuticals and human urine using calmagite as an ion-pair reagent,” Chemical Industry Chemical Engineering Qurterly, vol. 17, no. 3, pp. 259–267, 2011. View at Google Scholar
  30. S. Mostafa, M. El-Sadek, and E. A. Alla, “Spectrophotometric determination of enrofloxacin and pefloxacin through ion-pair complex formation,” Journal of Pharmaceutical and Biomedical Analysis, vol. 28, no. 1, pp. 173–180, 2002. View at Publisher · View at Google Scholar · View at Scopus
  31. K. Basavaiah, SriLatha, and J. M. Swamy, “Spectrophotometric determination of ceterizine hydrochloride with Alizarin Red S,” Talanta, vol. 50, no. 4, pp. 887–892, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. M. S. Kamel, B. N. Barsoum, and R. Sayed, “Spectrophotometric microdetermination of anthelmentic drug in pure form and pharmaceutical formulation by ion-pair complexation,” Journal of Applied Science Research, vol. 4, no. 10, pp. 1242–1248, 2008. View at Google Scholar
  33. S. A. M. Abdulrahman and K. Basavaiah, “Use of alizarin red S as a chromogenic agent for the colorimetric determination of dothiepin hydrochloride in pharmaceutical formulations,” Journal of Saudi Chemical Society. In press. View at Publisher · View at Google Scholar
  34. M. V. Cañamares, P. Sevilla, S. Sanchez-Cortes, and J. V. Garcia-Ramos, “Surface-enhanced Raman scattering study of the interaction of red dye alizarin with ovalbumin,” Biopolymers, vol. 82, no. 4, pp. 405–409, 2006. View at Publisher · View at Google Scholar · View at Scopus
  35. A. A. Nemodruk and Z. K. Karalova, Analytical Chemistry of Boron, Ann Arbor-Humphrey Science, London, UK, 1969.
  36. A. S. Amin, A. A. E. Gouda, R. El-Sheikh, and F. Zahran, “Spectrophotometric determination of gatifloxacin in pure form and in pharmaceutical formulation,” Spectrochimica Acta A, vol. 67, no. 5, pp. 1306–1312, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. “Validation of analytical procedures: text and methodology, Q2 (R 1), complementary guideline on methodology dated 06 November 1996,” in Proceedings of the International Conference on Harmonization of Technical Requirements Registration of Pharmaceuticals for Human Use, ICH Harmonized Guideline, London, UK, November 2005.